Su Qi-Song, Zhuang Dong-Lin, Nasser Moussa Ide, Sai Xiyalatu, Deng Gang, Li Ge, Zhu Ping
Medical Research Center, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510100, Guangdong, China.
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510080, Guangdong, China.
Cell Mol Neurobiol. 2023 Mar;43(2):491-510. doi: 10.1007/s10571-022-01204-9. Epub 2022 Feb 7.
Ischemic damage to the central nervous system (CNS) is a catastrophic postoperative complication of aortic occlusion subsequent to cardiovascular surgery that can cause brain impairment and sometimes even paraplegia. Over recent years, numerous studies have investigated techniques for protecting and revascularizing the nervous system during intraoperative ischemia; however, owing to a lack of knowledge of the physiological distinctions between the brain and spinal cord, as well as the limited availability of testing techniques and treatments for ischemia-reperfusion injury, the cause of brain and spinal cord ischemia-reperfusion injury remains poorly understood, and no adequate response steps are currently available in the clinic. Given the limited ability of the CNS to repair itself, it is of great clinical value to make full use of the proliferative and differentiation potential of stem cells to repair nerves in degenerated and necrotic regions by stem cell transplantation or mobilization, thereby introducing a novel concept for the treatment of severe CNS ischemia-reperfusion injury. This review summarizes the most recent advances in stem cell therapy for ischemia-reperfusion injury in the brain and spinal cord, aiming to advance basic research and the clinical use of stem cell therapy as a promising treatment for this condition.
中枢神经系统(CNS)的缺血性损伤是心血管手术后主动脉阻断导致的灾难性术后并发症,可引起脑功能损害,有时甚至导致截瘫。近年来,众多研究探讨了术中缺血期间保护神经系统及使其血管再通的技术;然而,由于对脑和脊髓生理差异的认识不足,以及针对缺血再灌注损伤的检测技术和治疗方法有限,脑和脊髓缺血再灌注损伤的原因仍知之甚少,目前临床上也没有足够的应对措施。鉴于中枢神经系统自身修复能力有限,充分利用干细胞的增殖和分化潜能,通过干细胞移植或动员来修复退变和坏死区域的神经,从而为治疗严重的中枢神经系统缺血再灌注损伤引入了一个新的概念,具有重要的临床价值。本综述总结了脑和脊髓缺血再灌注损伤干细胞治疗的最新进展,旨在推动干细胞治疗作为这种疾病的一种有前景的治疗方法的基础研究和临床应用。